APO Research
Talk to an analyst

APO RESEARCH · REPORT

Saphris (Asenapine)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Saphris (Asenapine) Market Outlook and Growth Opportunities 2026

22 December 2025198 pages

Choose your research edition.

Industry ResearchSaphris (Asenapine) Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Saphris (Asenapine) Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Saphris (Asenapine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Saphris (Asenapine) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Saphris (Asenapine) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Saphris (Asenapine) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Saphris (Asenapine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Saphris (Asenapine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Saphris (Asenapine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Saphris (Asenapine) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Saphris (Asenapine) market include Merck & Co., Inc., Allergan plc (AbbVie Inc.) and Actavis Generics (Teva), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Saphris (Asenapine) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Saphris (Asenapine) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Saphris (Asenapine) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Saphris (Asenapine) market size, projected growth trends, production technologies, key applications, and end-use industries.

Saphris (Asenapine) Segment by Company

Merck & Co., Inc.

Allergan plc (AbbVie Inc.)

Actavis Generics (Teva)

Saphris (Asenapine) Segment by Type

5 mg

10 mg

Saphris (Asenapine) Segment by Application

Schizophrenia

Acute Mania

Others

Saphris (Asenapine) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Saphris (Asenapine) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Saphris (Asenapine) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Saphris (Asenapine) significant trends, drivers, influence factors in global and regions.

6. To analyze Saphris (Asenapine) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Saphris (Asenapine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Saphris (Asenapine) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Saphris (Asenapine).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Saphris (Asenapine) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Saphris (Asenapine) industry.

Chapter 3: Detailed analysis of Saphris (Asenapine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Saphris (Asenapine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Saphris (Asenapine) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Saphris (Asenapine) Industry Trends Table 2. Saphris (Asenapine) Industry Drivers Table 3. Saphris (Asenapine) Industry Opportunities and Challenges Table 4. Saphris (Asenapine) Industry Restraints Table 5. Global Saphris (Asenapine) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Saphris (Asenapine) Revenue Share by Company (2021-2026) Table 7. Global Saphris (Asenapine) Sales Volume by Company (k units) & (2021-2026) Table 8. Global Saphris (Asenapine) Sales Volume Share by Company (2021-2026) Table 9. Global Saphris (Asenapine) Average Price (US$/unit) of Company (2021-2026) Table 10. Global Saphris (Asenapine) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Saphris (Asenapine) Key Company Manufacturing Base & Headquarters Table 12. Global Saphris (Asenapine) Company, Product Type & Application Table 13. Global Saphris (Asenapine) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Saphris (Asenapine) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 5 mg Table 18. Significant Companies of 10 mg Table 19. Global Saphris (Asenapine) Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Saphris (Asenapine) Sales Volume by Type (2021-2026) & (k units) Table 21. Global Saphris (Asenapine) Sales Volume by Type (2027-2032) & (k units) Table 22. Global Saphris (Asenapine) Sales Volume Share by Type (2021-2026) Table 23. Global Saphris (Asenapine) Sales Volume Share by Type (2027-2032) Table 24. Global Saphris (Asenapine) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Saphris (Asenapine) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Saphris (Asenapine) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Saphris (Asenapine) Sales Value Share by Type (2021-2026) Table 28. Global Saphris (Asenapine) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Schizophrenia Table 30. Significant Companies of Acute Mania Table 31. Significant Companies of Others Table 32. Global Saphris (Asenapine) Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Saphris (Asenapine) Sales Volume by Application (2021-2026) & (k units) Table 34. Global Saphris (Asenapine) Sales Volume by Application (2027-2032) & (k units) Table 35. Global Saphris (Asenapine) Sales Volume Share by Application (2021-2026) Table 36. Global Saphris (Asenapine) Sales Volume Share by Application (2027-2032) Table 37. Global Saphris (Asenapine) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Saphris (Asenapine) Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Saphris (Asenapine) Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Saphris (Asenapine) Sales Value Share by Application (2021-2026) Table 41. Global Saphris (Asenapine) Sales Value Share by Application (2027-2032) Table 42. Global Saphris (Asenapine) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Saphris (Asenapine) Sales by Region (2021-2026) & (k units) Table 44. Global Saphris (Asenapine) Sales Market Share by Region (2021-2026) Table 45. Global Saphris (Asenapine) Sales by Region (2027-2032) & (k units) Table 46. Global Saphris (Asenapine) Sales Market Share by Region (2027-2032) Table 47. Global Saphris (Asenapine) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Saphris (Asenapine) Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Saphris (Asenapine) Sales Value Share by Region (2021-2026) Table 50. Global Saphris (Asenapine) Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Saphris (Asenapine) Sales Value Share by Region (2027-2032) Table 52. Global Saphris (Asenapine) Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Saphris (Asenapine) Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Saphris (Asenapine) Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Saphris (Asenapine) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Saphris (Asenapine) Sales by Country (2021-2026) & (k units) Table 57. Global Saphris (Asenapine) Sales Market Share by Country (2021-2026) Table 58. Global Saphris (Asenapine) Sales by Country (2027-2032) & (k units) Table 59. Global Saphris (Asenapine) Sales Market Share by Country (2027-2032) Table 60. Global Saphris (Asenapine) Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Saphris (Asenapine) Sales Value Market Share by Country (2021-2026) Table 62. Global Saphris (Asenapine) Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Saphris (Asenapine) Sales Value Market Share by Country (2027-2032) Table 64. Merck & Co., Inc. Company Information Table 65. Merck & Co., Inc. Business Overview Table 66. Merck & Co., Inc. Saphris (Asenapine) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Merck & Co., Inc. Saphris (Asenapine) Product Portfolio Table 68. Merck & Co., Inc. Recent Development Table 69. Allergan plc (AbbVie Inc.) Company Information Table 70. Allergan plc (AbbVie Inc.) Business Overview Table 71. Allergan plc (AbbVie Inc.) Saphris (Asenapine) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Allergan plc (AbbVie Inc.) Saphris (Asenapine) Product Portfolio Table 73. Allergan plc (AbbVie Inc.) Recent Development Table 74. Actavis Generics (Teva) Company Information Table 75. Actavis Generics (Teva) Business Overview Table 76. Actavis Generics (Teva) Saphris (Asenapine) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Actavis Generics (Teva) Saphris (Asenapine) Product Portfolio Table 78. Actavis Generics (Teva) Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. Saphris (Asenapine) Distributors List Table 82. Saphris (Asenapine) Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Saphris (Asenapine) Product Image Figure 2. Global Saphris (Asenapine) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Saphris (Asenapine) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Saphris (Asenapine) Sales (2021-2032) & (k units) Figure 5. Global Saphris (Asenapine) Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Saphris (Asenapine) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 5 mg Image Figure 10. 10 mg Image Figure 11. Global Saphris (Asenapine) Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Saphris (Asenapine) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Saphris (Asenapine) Sales Volume Share by Type (2021-2032) Figure 14. Global Saphris (Asenapine) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Saphris (Asenapine) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Saphris (Asenapine) Sales Value Share by Type (2021-2032) Figure 17. Schizophrenia Image Figure 18. Acute Mania Image Figure 19. Others Image Figure 20. Global Saphris (Asenapine) Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Saphris (Asenapine) Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Saphris (Asenapine) Sales Volume Share by Application (2021-2032) Figure 23. Global Saphris (Asenapine) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Saphris (Asenapine) Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Saphris (Asenapine) Sales Value Share by Application (2021-2032) Figure 26. Global Saphris (Asenapine) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Saphris (Asenapine) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Saphris (Asenapine) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Saphris (Asenapine) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Saphris (Asenapine) Sales Value (2021-2032) & (US$ Million) Figure 31. North America Saphris (Asenapine) Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Saphris (Asenapine) Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Saphris (Asenapine) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Saphris (Asenapine) Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Saphris (Asenapine) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Saphris (Asenapine) Sales Value (2021-2032) & (US$ Million) Figure 37. South America Saphris (Asenapine) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Saphris (Asenapine) Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Saphris (Asenapine) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Saphris (Asenapine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Saphris (Asenapine) Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Saphris (Asenapine) Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg
  • 10 mg
Applications
  • Schizophrenia
  • Acute Mania
  • Others
Companies covered
  • Merck & Co., Inc.
  • Allergan plc (AbbVie Inc.)
  • Actavis Generics (Teva)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Saphris (Asenapine) Sales Value (2021-2032)
  4. 1.2.2 Global Saphris (Asenapine) Sales Volume (2021-2032)
  5. 1.2.3 Global Saphris (Asenapine) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Saphris (Asenapine) Market Dynamics
  1. 2.1 Saphris (Asenapine) Industry Trends
  2. 2.2 Saphris (Asenapine) Industry Drivers
  3. 2.3 Saphris (Asenapine) Industry Opportunities and Challenges
  4. 2.4 Saphris (Asenapine) Industry Restraints
3 Saphris (Asenapine) Market by Company
  1. 3.1 Global Saphris (Asenapine) Company Revenue Ranking in 2025
  2. 3.2 Global Saphris (Asenapine) Revenue by Company (2021-2026)
  3. 3.3 Global Saphris (Asenapine) Sales Volume by Company (2021-2026)
  4. 3.4 Global Saphris (Asenapine) Average Price by Company (2021-2026)
  5. 3.5 Global Saphris (Asenapine) Company Ranking (2024-2026)
  6. 3.6 Global Saphris (Asenapine) Company Manufacturing Base and Headquarters
  7. 3.7 Global Saphris (Asenapine) Company Product Type and Application
  8. 3.8 Global Saphris (Asenapine) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Saphris (Asenapine) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Saphris (Asenapine) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Saphris (Asenapine) Market by Type
  1. 4.1 Saphris (Asenapine) Type Introduction
  2. 4.1.1 5 mg
  3. 4.1.2 10 mg
  4. 4.2 Global Saphris (Asenapine) Sales Volume by Type
  5. 4.2.1 Global Saphris (Asenapine) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Saphris (Asenapine) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Saphris (Asenapine) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Saphris (Asenapine) Sales Value by Type
  9. 4.3.1 Global Saphris (Asenapine) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Saphris (Asenapine) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Saphris (Asenapine) Sales Value Share by Type (2021-2032)
5 Saphris (Asenapine) Market by Application
  1. 5.1 Saphris (Asenapine) Application Introduction
  2. 5.1.1 Schizophrenia
  3. 5.1.2 Acute Mania
  4. 5.1.3 Others
  5. 5.2 Global Saphris (Asenapine) Sales Volume by Application
  6. 5.2.1 Global Saphris (Asenapine) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Saphris (Asenapine) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Saphris (Asenapine) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Saphris (Asenapine) Sales Value by Application
  10. 5.3.1 Global Saphris (Asenapine) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Saphris (Asenapine) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Saphris (Asenapine) Sales Value Share by Application (2021-2032)
6 Saphris (Asenapine) Regional Sales and Value Analysis
  1. 6.1 Global Saphris (Asenapine) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Saphris (Asenapine) Sales by Region (2021-2032)
  3. 6.2.1 Global Saphris (Asenapine) Sales by Region: 2021-2026
  4. 6.2.2 Global Saphris (Asenapine) Sales by Region (2027-2032)
  5. 6.3 Global Saphris (Asenapine) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Saphris (Asenapine) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Saphris (Asenapine) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Saphris (Asenapine) Sales Value by Region (2027-2032)
  9. 6.5 Global Saphris (Asenapine) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Saphris (Asenapine) Sales Value (2021-2032)
  12. 6.6.2 North America Saphris (Asenapine) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Saphris (Asenapine) Sales Value (2021-2032)
  15. 6.7.2 Europe Saphris (Asenapine) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Saphris (Asenapine) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Saphris (Asenapine) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Saphris (Asenapine) Sales Value (2021-2032)
  21. 6.9.2 South America Saphris (Asenapine) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Saphris (Asenapine) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Saphris (Asenapine) Sales Value Share by Country, 2025 VS 2032
7 Saphris (Asenapine) Country-level Sales and Value Analysis
  1. 7.1 Global Saphris (Asenapine) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Saphris (Asenapine) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Saphris (Asenapine) Sales by Country (2021-2032)
  4. 7.3.1 Global Saphris (Asenapine) Sales by Country (2021-2026)
  5. 7.3.2 Global Saphris (Asenapine) Sales by Country (2027-2032)
  6. 7.4 Global Saphris (Asenapine) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Saphris (Asenapine) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Saphris (Asenapine) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Saphris (Asenapine) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Saphris (Asenapine) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Saphris (Asenapine) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck & Co., Inc.
  2. 8.1.1 Merck & Co., Inc. Company Information
  3. 8.1.2 Merck & Co., Inc. Business Overview
  4. 8.1.3 Merck & Co., Inc. Saphris (Asenapine) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck & Co., Inc. Saphris (Asenapine) Product Portfolio
  6. 8.1.5 Merck & Co., Inc. Recent Developments
  7. 8.2 Allergan plc (AbbVie Inc.)
  8. 8.2.1 Allergan plc (AbbVie Inc.) Company Information
  9. 8.2.2 Allergan plc (AbbVie Inc.) Business Overview
  10. 8.2.3 Allergan plc (AbbVie Inc.) Saphris (Asenapine) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Allergan plc (AbbVie Inc.) Saphris (Asenapine) Product Portfolio
  12. 8.2.5 Allergan plc (AbbVie Inc.) Recent Developments
  13. 8.3 Actavis Generics (Teva)
  14. 8.3.1 Actavis Generics (Teva) Company Information
  15. 8.3.2 Actavis Generics (Teva) Business Overview
  16. 8.3.3 Actavis Generics (Teva) Saphris (Asenapine) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Actavis Generics (Teva) Saphris (Asenapine) Product Portfolio
  18. 8.3.5 Actavis Generics (Teva) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Saphris (Asenapine) Value Chain Analysis
  2. 9.1.1 Saphris (Asenapine) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Saphris (Asenapine) Sales Mode & Process
  6. 9.2 Saphris (Asenapine) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Saphris (Asenapine) Distributors
  9. 9.2.3 Saphris (Asenapine) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst